The Compassionate IND Program: The Americans Who Still Get Free Federal Weed

Every month for more than forty years, the United States government has shipped a Florida stockbroker a sealed steel tin containing around 300 pre-rolled cannabis cigarettes.

The same government spent most of those decades classifying cannabis as a drug with no accepted medical use, and prosecuting people for far less than the contents of one tin.

Both things were administered by the same agencies, at the same time, on purpose. This is the story of how that happened, who is still receiving, and what it quietly proves.

The short answer

A 1976 court ruling forced the government's hand, a 1978 settlement created a program, and by 1992 it was closed to new entrants in a panic, with the surviving patients grandfathered for life.

At its peak it supplied roughly 13 to 15 people. As of the most recent reporting, it survives, and so does its most famous patient.

The glaucoma patient who beat the government

Robert Randall was a young Washington DC man going blind from glaucoma who discovered that cannabis relieved the pressure in his eyes when nothing prescribed did. Arrested in 1975 for growing his own, he did something almost nobody did then: he fought on medical necessity.

On November 24, 1976, a DC Superior Court judge ruled in his favor, writing that while blindness was shown by competent medical testimony to be the otherwise inevitable result of his disease, no adverse effects from the smoking of marijuana have been demonstrated, and in a line that still lands, that the evil he sought to avert, blindness, is greater than that he performed to accomplish it.

That same month, a federally supplied batch of cannabis cigarettes reached him through an FDA-approved investigational application. When agencies later cut off his supply, he sued, and within a day of filing the government asked to settle. The 1978 settlement gave him ongoing access through a federal pharmacy, and became the legal foundation of the Compassionate Investigational New Drug program.

One stubborn patient, one honest judge, and the federal government became a medical cannabis supplier a full 18 years before California passed the first state law.

How the program works

The mechanics have barely changed in four decades, and they are wonderfully strange. The cannabis grows at the University of Mississippi, the government's sole licensed research farm since 1968. The harvest travels to a  facility in North Carolina, where machines roll it into uniform cigarettes. Roughly 300 of them, about half a pound, are packed into a steel tin and shipped monthly to a designated local pharmacy, where the patient collects it like any other prescription.

By 2011, the program had shipped an estimated 584 pounds over its lifetime. The product itself was never impressive: patients described potency around 3 to 4 percent, freeze-dried, sometimes years old by its own date stamps, full of stems and seeds. One reviewer shown government cannabis in 2017 said it did not resemble cannabis and did not smell like cannabis, and a strain labeled 13 percent THC tested closer to 8.

The recipients smoked it anyway, for decades, because it was legal, free and reliable, which is a sentence about what patients actually need that the industry still has not fully absorbed.

The AIDS surge, and the door slamming shut

Through the 1980s the program stayed tiny, just a handful of patients with glaucoma, rare bone disease and multiple sclerosis. Then AIDS arrived, and cannabis turned out to help with wasting syndrome when nearly nothing else did.

In 1991 Randall launched a service helping AIDS patients file applications, and hundreds poured in. The government looked at the prospect of visibly supplying cannabis to a large population of sick young men and shut the door: new admissions were suspended in mid-1991 and the program officially terminated on March 19, 1992, with the 13 existing patients grandfathered.

The head of the Public Health Service explained the reasoning with unusual candor, saying that if it were perceived that the government was going around giving marijuana to folks, there would be a perception that this stuff can't be so bad.

Read that twice. The stated concern was not safety. It was that the program's existence undermined the message.

The unexamined day is a wasted opportunity. Reflect on what you did, what you learned, and how you can improve.

John Dewey

Irvin Rosenfeld, patient number two

The program's living face is a stockbroker from Fort Lauderdale with a rare disorder that covers his bones with tumors.

Irvin Rosenfeld received his first federal tin on November 20, 1982, and has collected roughly ten cigarettes a day from his pharmacy ever since, while working a full career in finance. By 2016 his own estimate stood at around 135,000 joints over 34 years, supplied entirely by the federal government, and his tumors had neither grown nor multiplied. He wrote a book about it called My Medicine and has spent decades pointing at his own tins as an argument.

His standing line: the United States federal government has been supplying me ten marijuana cigarettes per day for over thirty years.

The most recent reporting, from May 2025, still counts Rosenfeld, now in his seventies, and glaucoma patient Elvy Musikka as the last two beneficiaries, while noting the official count of active patients as two as of 2023. Musikka's status is genuinely murky, with earlier reporting suggesting supply problems after she moved to Oregon. The others are gone: George McMahon, patient for nail-patella syndrome, died in 2019; Barbara Douglass, patient thirteen and the last approved, died in 2018.

Somewhere between one and two people still receive. The program will end as a matter of actuarial fact, not policy, which is its own kind of statement.

What it proves, and what changed in 2026

The program's real significance was always the contradiction it embodied. Schedule I means no currently accepted medical use. For the entire life of that classification, the same government maintained a farm, a rolling contract, a pharmacy channel and a patient file explicitly premised on medical use, and the 1999 Institute of Medicine report the government itself commissioned acknowledged that for some chronic patients there was no clear alternative and recommended exactly the kind of supervised single-patient access the program already was.

The April 2026 rescheduling made the irony official without resolving it. FDA-approved products and state-licensed medical cannabis moved to Schedule III, while everything else stayed in Schedule I, and nothing in the order mentions the Compassionate IND patients at all. The man with the tins predates the entire framework being argued over.

Meanwhile the Ole Miss monopoly that grew his supply ended in 2021 when the DEA licensed additional growers, and in 2025 the government quietly stopped issuing new cultivation orders to the university under a cost-cutting directive. The farm that supplied a one-man refutation of federal policy for four decades is winding down with it.

What a seed company sees in this story

Two things, and they are the same thing. Rosenfeld's cannabis was, by every account, mediocre: low potency, badly stored, stems and all. It also kept a man with a catastrophic bone condition working full time for forty years, because the variable that mattered was continuity, not quality. He had the same medicine, on the same schedule, forever. Almost nobody else in America has ever had that.

Home growing is the only version of that reliability available to an ordinary person. Not the government's tins, but the same principle: your supply, your consistency, nobody's permission expiring.

Insane OG is the heritage pick here, OG Kush crossed with Bubba Kush and Granddaddy Purple, a 75% indica at 32% THC, flowering in 55 to 65 days at 100 to 120 cm indoors with up to 2,000 grams a plant outdoors, earthy gas and grape with a calm, sociable finish. Lemon Tree is Lemon Skunk crossed with Sour Diesel, a 55% indica at 28%, 65 to 70 days and compact at 90 to 100 cm, fresh lemon over skunk and diesel, happy and relaxing, and notably easy to grow.

Four decades of breeding overlaps almost exactly with the four decades of Rosenfeld's tins. We would like to think the plants improved a little more than the government's did.

The short version

A 1976 medical necessity ruling and a 1978 settlement forced the federal government to supply cannabis to individual patients, grown at Ole Miss and shipped monthly as tins of about 300 pre-rolled cigarettes.

The program peaked at roughly 13 to 15 patients, closed to new entrants in March 1992 after a surge of AIDS applications, and grandfathered the rest for life. Irvin Rosenfeld, enrolled in 1982, has received on the order of 135,000 federal joints and was still receiving as of the most recent reporting, with at most one other patient remaining.

The government ran this program through every year it maintained that cannabis has no accepted medical use, and the April 2026 partial rescheduling does not mention it. The last tins will simply outlive the argument.

Barney's Farm has been developing premium cannabis genetics since the 1980s, with over 40 Cannabis Cup wins. Explore our full seed catalog and find strains bred for every climate and skill level.